NEM
30
2
AMP
43
2
MET
58
2
ADT
12
2
COP
36
2
DOV
48
2
GWW
50
9
HES
49
2
FIS
43
5
LEN
21
3
GM
55
6
NWSA
69
4
ACN
54
2
GE
60
5
HAS
29
3
PHM
44
4
DGX
28
4
MO
47
6
LNC
28
3
CVS
27
2
NEM
30
2
AMP
43
2
MET
58
2
ADT
12
2
COP
36
2
DOV
48
2
GWW
50
9
HES
49
2
FIS
43
5
LEN
21
3
GM
55
6
NWSA
69
4
ACN
54
2
GE
60
5
HAS
29
3
PHM
44
4
DGX
28
4
MO
47
6
LNC
28
3
CVS
27
2
Financhill
Back

Summit Therapeutics Vs. Nukkleus Industry Stock Comparison

Sell
31

SMMT
Summit Therapeutics

Last Price:
$17.89
Seasonality Move:
18.6%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
31
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $17.87. The Score for SMMT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $17.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 45.88 Sell
Chaikin Money Flow: -4547899 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.79 - 19.07) Sell
Bollinger Bands (100): (13.59 - 22.67) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.12 Sell
20-day SMA: 18.32 Sell
50-day SMA: 19.47 Sell
200-day SMA: 12.04 Buy
8-day EMA: 18.07 Sell
20-day EMA: 18.39 Sell
50-day EMA: 18.72 Sell
200-day EMA: 13.66 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.08 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):